# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Fyodor Dostoevsky (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI018-SYN
- Date: 2026-07-07
- Fictional facility: St. Posthumous Health Center
- Fictional author: Agnes Lindahl, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-month review of seizure control, mood, and gambling recovery. **S**

## History of present illness

Mr. Dostoevsky returns four months after starting lamotrigine. He has had no seizure since the one in the third week of the titration, about sixteen weeks ago, including during the stomach illness last month, when he missed two doses. He has no side effects. He has not gambled for five months, although urges came back when an advance from his publisher arrived; he called his therapist and a friend instead. He has finished twelve therapy sessions and now goes every two weeks, and he attends Gamblers Anonymous most weeks. The debt repayment plan has started. He is planning a long research trip abroad in late summer. His mood is good. **S**

| Element | Detail |
|---|---|
| Seizures | None for about sixteen weeks |
| Lamotrigine | 100 mg twice daily; no side effects; two doses missed during the stomach illness |
| Gambling | None for five months; urges handled with his coping plan |
| Plans | A long trip abroad in late summer |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Neurological | Negative | No seizures, dizziness, double vision, or unsteadiness |
| Integumentary | Negative | No rash |
| Psychiatric | Negative | Mood good; occasional urges; no thoughts of suicide or self-harm |

3 systems reviewed. **S**

## Current medications

- Lamotrigine 100 mg tablet, one tablet twice daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 120/78 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 68.6 kg; BMI 23.7 kg/m². All vital signs are synthetic.

PHQ-9: 5. All results are synthetic.

## Change since baseline

- PHQ-9: 8 at baseline, 5 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 68.6 kg; blood pressure 120/78, heart rate 70 |
| Neurological | No nystagmus or ataxia |
| Psychiatric | Euthymic and future-oriented |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Epilepsy of unknown type on lamotrigine** (G40.909). No seizure for about sixteen weeks on a well-tolerated dose. **S**
   - Continue lamotrigine 100 mg twice daily.
   - Travel plan: carry a three-month supply in his hand luggage with a letter listing his diagnosis and medicine, keep doses on home time with alarms and shift them gradually across time zones, and protect sleep on the journey.
2. **Gambling disorder** (F63.0). Abstinent for five months. The trip abroad is a high-risk period, because his self-exclusion does not cover casinos in other countries. Safety reviewed: no thoughts of suicide. **S**
   - Agree a travel plan with his therapist before he leaves: carry only a set amount of cash, keep the bank block, avoid spa and resort towns with casinos, and book telehealth sessions while away.
   - Continue therapy every two weeks and Gamblers Anonymous.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Seizure frequency, seizure diary, and seizure description | Every visit | Completed today | No seizure for about sixteen weeks |
| Medication safety | Antiseizure medicine adverse effects (dizziness, double vision, unsteadiness, sleep, mood) | Every visit | Completed today | None |
| Medication safety | Rash and mouth-sore check (lamotrigine) | Every contact during titration and the first two months, then with symptoms | Not indicated | Past the first two months without rash; asked only about symptoms |
| Medication safety | Adherence and missed doses | Every visit | Completed today | Two doses missed during the stomach illness last month; none otherwise |
| Laboratory | Lamotrigine trough level | Once at steady state as a reference, then with breakthrough seizures, suspected nonadherence, or interacting medicines | Up to date | Reference level 6.2 ug/mL two months ago; no new indication |
| Self-management | Trigger review: sleep loss, alcohol, overwork, missed doses | Every visit | Completed today | Sleeping seven hours; travel and time-zone changes discussed as new risks |
| Self-management | Seizure safety and driving counseling | At diagnosis and every visit | Completed today | Not driving; precautions followed; travel safety discussed |
| Self-management | SUDEP discussion | At diagnosis and when seizure control changes | Up to date | Discussed with neurology four months ago; control has improved |
| Survey | Depression screen (PHQ-9) | At intake, then every two to four months while symptoms are present | Completed today | PHQ-9 5, item 9 scored 0 |
| Survey | Suicide-risk review and safety plan, with the 988 Suicide & Crisis Lifeline | Every visit (gambling disorder and antiseizure-medicine labeling) | Completed today | No thoughts of suicide |
| Survey | Gambling since the last visit: days, money lost, and urges (G-SAS for the past week) | Every visit | Completed today | No gambling for five months; G-SAS 8 for the past week |
| Self-management | Cognitive behavioral therapy for gambling disorder | Weekly sessions for at least 8 to 12 weeks, then as needed | Completed today | Twelve weekly sessions completed; now every two weeks; telehealth to be booked for the trip |
| Self-management | Self-exclusion from casinos and online gambling | At the start of treatment; renew and extend after any lapse | Up to date | In place at home; does not cover casinos abroad |
| Self-management | Financial safeguards (bank gambling block, co-signer for large withdrawals, limited cash) | At the start of treatment | Up to date | Bank block and co-signer in place; set cash amount agreed for the trip |
| Referral | Peer support (Gamblers Anonymous) | Offered at the start of treatment and after any lapse | Up to date | Attends most weeks |
| Referral | Debt counseling | Once, early in treatment | Up to date | Repayment plan started |
| Medication safety | Medicine for gambling disorder (opioid antagonist) | Considered if psychological treatment alone is not enough | Not indicated | Responding to psychological treatment |
| Referral | Neurology review | In January, or sooner after a breakthrough seizure | Up to date | Next review in January |

## Goal progress

- Reach the lamotrigine maintenance dose without rash by the two-month visit. Outcome by 2026-05-05: Maintenance dose of 100 mg twice daily reached after six weeks; no rash. **S**
- No seizures for six months after reaching the maintenance dose. In progress; target 2026-10-06. **S**
- Casino and online self-exclusion and a bank gambling block in place by the four-week visit. Outcome by 2026-03-03: Self-exclusion from casinos in the state and from licensed online sites, and a gambling block on his bank cards, in place. **S**
- No gambling through the eight-month visit. In progress; target 2026-10-06. **S**
- Written seizure action plan, safety counseling, and a SUDEP discussion completed by the four-week visit. Outcome by 2026-03-03: Plan written and shared with two friends; SUDEP discussed with the neurologist. **S**

## Guideline basis

- Evidence-based guideline: Management of an unprovoked first seizure in adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society (2015), American Academy of Neurology and American Epilepsy Society (Neurology)
- Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy (2018), American Academy of Neurology and American Epilepsy Society (Neurology)
- Psychological therapies for pathological and problem gambling (2012), Cochrane Database of Systematic Reviews
- Gambling disorder (2019), Nature Reviews Disease Primers
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026), Aether Forge

## Follow-up

- Eight-month review after his trip. Call or message from abroad after any seizure. **S**
- Next scheduled visit 2026-10-06: eight-month review after a breakthrough seizure and a gambling lapse while traveling. **S**
